NCT00209391View on ClinicalTrials.gov

A Safety & Efficacy Clinical Study to Evaluate the Narrowing of the Renal Arteries While Using Gadodiamide

PHASE3CompletedINTERVENTIONAL
Enrollment

395

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

August 1, 2005

Study Completion Date

August 1, 2005

Conditions
Renal Artery Stenosis
Interventions
DRUG

Gadodiamide Injection

Trial Locations (1)

Unknown

Amersham Buchler GmbH & Co. KG, Ismaning

Sponsors

Lead Sponsor

GE Healthcare
All Listed Sponsors
lead

GE Healthcare

INDUSTRY